Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Anita P. McSwain"'
Autor:
Andrew D. Sparks, Claire Edwards, Tammy Ju, Anita P. McSwain, Christine B. Teal, Cecilia Rossi
Publikováno v:
Cancer Science & Research. 1
Autor:
Judith F. Vacchino, Joseph Stilwill, Dasha Cherepanov, Eunice Chang, Wendy C. Hsiao, Christine B. Teal, J. Stanley Smith, Michael Schultz, Michael S. Broder, Kevin Fox, Thomas G. Frazier, Tracey Weisberg, Amy P. Sing, Anita P. McSwain, Christine Laronga, Devchand Paul
Publikováno v:
Pharmaceuticals, Vol 8, Iss 1, Pp 107-122 (2015)
Pharmaceuticals
Volume 8
Issue 1
Pages 107-122
Pharmaceuticals
Volume 8
Issue 1
Pages 107-122
To assess clinical utility of the 21-gene assay (Oncotype DX® Recurrence Score®), we determined whether women with HER2(−)/ER+ pN1mi breast cancer with low (<
18) Recurrence Scores results are given adjuvant chemotherapy in a lower proport
18) Recurrence Scores results are given adjuvant chemotherapy in a lower proport
Autor:
R. F. Brem, Anita P. McSwain, Jocelyn A. Rapelyea, C. Donnelly, A. B. Kidwell, Lauren R. Rechtman, Christine B. Teal, Caitrín M. Coffey, Jessica Torrente, Rache V. Tadwalkar
Publikováno v:
The British Journal of Radiology. 85:e212-e216
The purpose of this study was to determine the sensitivity of breast-specific gamma imaging (BSGI) in the detection of invasive breast cancers and to characterise the sensitivity of BSGI based on tumour size and pathological grade.139 females with in
Autor:
Lauren R. Rechtman, Alison B. Kidwell, Jocelyn A. Rapleyea, Anita P. McSwain, Christine B. Teal, Jessica Torrente, Colleen A. Donnelly, Cimmie Shahan, Rachel F. Brem
Publikováno v:
Academic Radiology. 17:735-743
Rationale and Objectives The aim of this study was to determine how often breast-specific gamma imaging (BSGI) identifies occult cancerous lesions in women with one suspicious lesion detected on mammography or physical exam. Materials and Methods A r
Autor:
Rachel F. Brem, Anita P McSwain, Jessica Torrente, Christine B. Teal, Jocelyn A Rapelyea, Caroline Sanchez
Publikováno v:
The American Surgeon. 76:331-334
One of the risks of breast conservation surgery is local recurrence, which predominantly occurs as a result of inadequate surgical margins. The purpose of this study was to identify factors associated with close or positive surgical margins leading t
Autor:
Sameer Damle, Jocelyn A. Rapelyea, Kara Downs, Anita P. McSwain, Rachel F. Brem, Claire Edwards, Christine B. Teal, Stephanie A. Williams, Jessica Torrente, Anita Sambamurty
Publikováno v:
The breast journal. 19(5)
Breast-specific gamma imaging (BSGI) is a physiologic breast imaging modality that provides more sensitive detection of breast lesions than mammography or ultrasound, and appears to have greater specificity than breast MRI. The purpose of this study
Autor:
Caroline M. Ling, Jocelyn A. Rapelyea, Caitrín M. Coffey, Anita P. McSwain, Christine B. Teal, Rachel F. Brem, Jessica Torrente
Publikováno v:
Academic radiology. 19(6)
Rationale and Objectives Atypical lesions such as atypical ductal hyperplasia (ADH) and lobular neoplasia are nonmalignant lesions that are associated with significant increased risk of developing breast cancer. Atypical lesions have been reported to
Autor:
Christine B. Teal, Elizabeth C. Marshall, Anita P. McSwain, Sameer Damle, Qing Pan, Joanne J. Lenert
Publikováno v:
Indian journal of surgical oncology. 2(2)
Background. Breast conservation surgery (BCS) followed by radiation is as effective as mastectomy for long-term survival and is considered standard of care for early-stage breast cancer. An increasing number of patients are opting for cancer-side mas
Autor:
Caroline, Sanchez, Rachel F, Brem, Anita P, McSwain, Jocelyn A, Rapelyea, Jessica, Torrente, Christine B, Teal
Publikováno v:
The American surgeon. 76(3)
One of the risks of breast conservation surgery is local recurrence, which predominantly occurs as a result of inadequate surgical margins. The purpose of this study was to identify factors associated with close or positive surgical margins leading t
Autor:
Martin Ojong-Ntui, Rebecca Kaltman, Stephanie A. Williams, Christine B. Teal, Robert S. Siegel, Imad A. Tabbara, Ashima Saini, Talar Tatarian, Anita P. McSwain
Publikováno v:
Journal of Clinical Oncology. 30:e11084-e11084
e11084 Background: Oncotype DX is a 21-gene assay developed for early stage, hormone receptor positive breast cancer that generates a Recurrence Score which estimates response to chemotherapy and the likelihood of systemic recurrence at 10 years. It